• As lawsuits increase, Johnson & Johnson discontinues talcum powder globally

    Business
    As lawsuits increase, Johnson & Johnson discontinues talcum powder globally

    Less than 1% of the company's shares increased in post-market trade, and as of Thursday's close, they had lost 2.3% of their value this year.

    Digital Desk: It has been years since
    the business withdrew the talc-based baby powder in the US and Canada, but
    Johnson & Johnson announced that it intends to stop selling its legacy
    talc-based baby powder products globally in 2023. This announcement comes amid
    ongoing legal disputes.



    Following an evaluation
    of its portfolio, J&J announced on Thursday that it has "commercially
    decided" to switch all of its baby powder products to cornstarch from
    talcum powder. Since roughly ten years ago, the health conglomerate has been
    the target of lawsuits alleging it concealed cancer risks associated with its
    talc-based baby powder. The company claims the product is safe.



    color:#2E2E2E">According to spokesperson Melissa Witt, "We regularly
    assess and improve our portfolio to best position the business for long-term
    success." "Today's decision is a result of an evaluation of our
    global portfolio that looked at a number of variables, including regional
    variations in the demand for our products and shifting consumer trends and
    tastes."



    Less than 1% of the
    company's shares increased in post-market trade, and as of Thursday's close,
    they had lost 2.3% of their value this year.



    color:#2E2E2E">In May 2020, J&J withdrew its talc-based powders from the US
    and Canadian markets, citing yet another "commercial decision" based
    on dwindling sales as it negotiated thousands of lawsuits alleging the
    substance had caused some users to get cancer.



    In a statement sent via
    email on Thursday, Leigh O'Dell, an attorney for former talc users, claimed that
    J&J had "finally done the right thing" after decades of marketing
    talc-based goods that the corporation knew might harm innocent women and men
    around the world by spreading lethal malignancies. "More than two years
    ago, they stopped making sales in North America. It is unacceptable that this
    action has been delayed."



    Talcum Powder



    Because
    the mineral keeps skin dry and reduces diaper rash, talcum powder has been a
    staple in infant products for a long time. However, the mines that create the
    powder can also produce asbestos, a material that was historically utilised in
    goods like building insulation and has been linked by experts to cancer.
    Consumer product firms have discovered that maize starch can provide talc's
    advantages without the asbestos concern.



    According to J&J,
    "our position on the safety of our cosmetic talc remains unaltered,"
    as of Thursday.



    color:#2E2E2E">The health company has been looking for strategies to limit its
    legal responsibilities for years. According to a business filing with the U.S.
    Securities and Exchange Commission made last month, it is facing 40,300
    lawsuits in the US for its talc-based powders.



    Last year, J&J
    claimed it was having difficulty controlling the claims and sought bankruptcy
    protection for its recently formed LTL Management LLC arm.



    .



    $2 Billion Trust



    For
    the purpose of resolving all present and future talc claims, the corporation
    placed $2 billion into a trust as part of the bankruptcy of the subsidiary. A
    judge declared in February that the case may move forward in order to pursue
    settlements, but his decision is currently being contested.



    Former talc users'
    attorneys have contested J&J's decision to have the unit file for Chapter
    11 protection in order to deal with the talc unit. On September 19, a federal
    appeals court in Philadelphia will examine the plaintiffs' assertions that the
    action constituted to a "bad faith" bankruptcy filing because they
    maintain that the talc litigation didn't pose a threat to J&J's financial
    standing.



    color:#2E2E2E">In court filings, as per J&J's attorneys, the corporation
    encountered difficulties in negotiating a broad settlement of the talc claims
    and had to deal with rising legal expenses. The drugmaker's counsel pointed out
    that over the past five years, it has spent more than $1 billion on legal fees
    related to the talc cases and has had to contend with conflicting jury
    decisions.



    J&J has previously had to pay out over
    $3.5 billion in settlements to resolve talc accusations, according to the
    company's bankruptcy documents. Following a 2018 jury decision in a St. Louis
    state court, J&J was ultimately compelled to pay $2.5 billion to 20 women
    who claimed that its baby powder caused their ovarian cancer. Neither the
    Missouri Supreme Court nor the US Supreme Court affirmed the verdict. According
    to legal experts, J&J wants to separate its consumer health business into a
    standalone company next year, a move that might help it isolate blame in the event
    that the Chapter 11 vehicle fails.